|
Delayed
Bombay S.E.
05:38:08 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 14.20 INR | +3.42% |
|
+18.33% | +312.79% |
Company Valuation: Integrated Proteins Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 10.38 | 48.05 | 38.35 | 51.93 | 127.2 | 1,361 |
| Change | - | 362.96% | -20.2% | 35.42% | 144.91% | 970.44% |
| Enterprise Value (EV) 1 | 8.971 | 48.5 | 39.99 | 51.67 | 165.3 | 1,362 |
| Change | - | 440.58% | -17.54% | 29.19% | 219.88% | 723.87% |
| P/E | 49x | 136x | 133x | 58.2x | 55.9x | 606x |
| PBR | 0.42x | 1.93x | 1.52x | 1.99x | 0.63x | 6.63x |
| PEG | - | 2.1x | -7.3x | 0x | 0x | -7.3x |
| Capitalization / Revenue | - | - | 22,962,331x | 21,874,623x | 591,653x | 13,695,220x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -8.79x | -62.7x | -47x | -43.7x | 164x | 465x |
| EV / EBIT | -6.85x | -45.7x | -35.1x | -35.7x | 181x | 481x |
| EV / FCF | -25.2x | -138x | -63.2x | -87.5x | -0.69x | 38.3x |
| FCF Yield | -3.97% | -0.72% | -1.58% | -1.14% | -144% | 2.61% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.006617 | 0.011 | 0.009 | 0.0279 | 0.071 | 0.012 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | 1.67 | 2.374 | 215 | 99.41 |
| EBITDA 1 | -1.021 | -0.774 | -0.85 | -1.182 | 1.009 | 2.929 |
| EBIT 1 | -1.309 | -1.062 | -1.138 | -1.446 | 0.913 | 2.833 |
| Net income 1 | 0.212 | 0.365 | 0.309 | 0.893 | 2.5 | 2.25 |
| Net Debt 1 | -1.408 | 0.443 | 1.644 | -0.265 | 38.08 | 0.156 |
| Reference price 2 | 0.32 | 1.50 | 1.20 | 1.62 | 3.97 | 7.28 |
| Nbr of stocks (in thousands) | 32,036 | 32,036 | 32,036 | 32,036 | 32,036 | 187,136 |
| Announcement Date | 9/1/21 | 8/17/22 | 8/28/23 | 8/6/24 | 9/6/25 | 9/8/26 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 27.05M | ||
| 21.75x | 2.94x | 14.46x | 3.77% | 258B | ||
| 19.4x | 2.49x | 14.84x | 3.3% | 79.58B | ||
| 16.55x | 1.72x | 9.76x | 3.79% | 44.17B | ||
| 14.46x | 0.52x | 9.3x | 2.67% | 37.69B | ||
| 19.94x | 3.05x | 12.39x | 3.51% | 33.05B | ||
| 34.98x | 3.03x | 17.65x | 1.06% | 30.9B | ||
| 26.02x | 5.48x | 17.46x | 3.22% | 29.65B | ||
| -8.48x | 1.85x | 9.24x | 6.67% | 28.53B | ||
| 18x | 1.72x | 12.18x | 4.74% | 27.4B | ||
| Average | 18.07x | 2.53x | 13.03x | 3.64% | 56.94B | |
| Weighted average by Cap. | 19.68x | 2.65x | 13.65x | 3.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INTEGFD6 Stock
- Valuation Integrated Proteins Limited
Select your edition
All financial news and data tailored to specific country editions
















